GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 319 filers reported holding GW PHARMACEUTICALS PLC in Q3 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $52,255,000 | -59.3% | 240,917 | -78.4% | 0.01% | -20.0% |
| Q4 2020 | $128,500,000 | +128.3% | 1,113,412 | +92.6% | 0.01% | 0.0% |
| Q3 2020 | $56,279,000 | +15.7% | 578,112 | +45.8% | 0.01% | -16.7% |
| Q2 2020 | $48,655,000 | -6.4% | 396,470 | -33.2% | 0.01% | -29.4% |
| Q1 2020 | $51,979,000 | -51.9% | 593,576 | -42.6% | 0.02% | -45.2% |
| Q4 2019 | $108,156,000 | -9.3% | 1,034,388 | -0.2% | 0.03% | -20.5% |
| Q3 2019 | $119,224,000 | -64.6% | 1,036,460 | -47.0% | 0.04% | -7.1% |
| Q2 2019 | $336,820,000 | +201.5% | 1,953,826 | +194.8% | 0.04% | -8.7% |
| Q1 2019 | $111,733,000 | +3.0% | 662,829 | -40.5% | 0.05% | +7.0% |
| Q4 2018 | $108,442,000 | -23.0% | 1,113,474 | +36.5% | 0.04% | -8.5% |
| Q3 2018 | $140,920,000 | +26.5% | 815,790 | +2.2% | 0.05% | +20.5% |
| Q2 2018 | $111,419,000 | +19.7% | 798,466 | -3.3% | 0.04% | +18.2% |
| Q1 2018 | $93,069,000 | +74.0% | 826,025 | +103.8% | 0.03% | +83.3% |
| Q4 2017 | $53,500,000 | -4.0% | 405,275 | -26.2% | 0.02% | -18.2% |
| Q3 2017 | $55,731,000 | +10.6% | 549,127 | +9.2% | 0.02% | 0.0% |
| Q2 2017 | $50,392,000 | -41.7% | 502,657 | -29.7% | 0.02% | -48.8% |
| Q1 2017 | $86,418,000 | -46.3% | 714,550 | -50.4% | 0.04% | -46.9% |
| Q4 2016 | $160,878,000 | +8.4% | 1,439,627 | +28.7% | 0.08% | +12.5% |
| Q3 2016 | $148,446,000 | +142.4% | 1,118,408 | +67.3% | 0.07% | +118.2% |
| Q2 2016 | $61,232,000 | +42.5% | 668,700 | +12.3% | 0.03% | +43.5% |
| Q1 2016 | $42,972,000 | -23.9% | 595,597 | -26.8% | 0.02% | -11.5% |
| Q4 2015 | $56,462,000 | +14.4% | 813,114 | +50.5% | 0.03% | +23.8% |
| Q3 2015 | $49,360,000 | -6.5% | 540,212 | +25.7% | 0.02% | -8.7% |
| Q2 2015 | $52,772,000 | +87.2% | 429,600 | +38.8% | 0.02% | +76.9% |
| Q1 2015 | $28,196,000 | -19.2% | 309,400 | -40.0% | 0.01% | -7.1% |
| Q4 2014 | $34,896,000 | -46.8% | 515,604 | -36.5% | 0.01% | -44.0% |
| Q3 2014 | $65,650,000 | -12.3% | 811,998 | +16.4% | 0.02% | -24.2% |
| Q2 2014 | $74,832,000 | +3131.1% | 697,463 | +1688.2% | 0.03% | +3200.0% |
| Q1 2014 | $2,316,000 | – | 39,003 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |